| ||
Billionaire Pharmaceutical Entrepreneur Makes Bet On Fast Growing ... Forbes Interestingly, the lead investor in the share raise was billionaire pharmaceutical entrepreneur Dr. Phillip Frost catapulting him to one of the largest holders of MSLP stock. Dr. Frost was chairman and CEO of IVAX Corp. which was sold in 2007 to ... See all stories on this topic » | ||
Indian Pharmaceutical Market Outlook - Enhanced purchasing power, rural ... PR Newswire India (press release) http://www.reportlinker.com/p01089005/Indian-Pharmaceutical-Market-Outlook---Enhanced-purchasing-power-rural-market-penetration-and-expanded-access-to-healthcare-attracting-Big-Pharma-investment.html#utm_source=prnewswire&utm_medium= ... See all stories on this topic » | ||
China Nuokang Bio-Pharmaceutical Inc. to Reconvene Adjourned Extraordinary ... NASDAQ BEIJING, Jan. 29, 2013 (GLOBE NEWSWIRE) -- China Nuokang Bio-Pharmaceutical Inc. (Nasdaq:NKBP) ("Nuokang" or the "Company") announced today that it will reconvene the extraordinary general meeting of shareholders (the "EGM") that was ... See all stories on this topic » | ||
| ||
Shasun Pharmaceutical's UK subsidiary would not be impacted from declining ... Economic Times MUMBAI: Shasun Pharmaceutical's stock gained 12.6% today after the company came out with an update on its UK subsidiary. In the communication to the investors filed on the stock exchanges, the company said that the declining performance of Incevik, key ... See all stories on this topic » | ||
| ||
10 years since West Pharmaceutical blast WNCT KINSTON, N.C. – It's been 10 years since a dust explosion in Kinston killed six people and injured dozens of others. The West Pharmaceutical Services Plant went up in flames back on January 29, 2003. A chemical safety board study says inspectors and ... See all stories on this topic » | ||
Aoxing Pharmaceutical receives production license For Pholcodine in China MENAFN.COM Jan 29, 2013 (Menafn - M2 EQUITYBITES via COMTEX) --Speciality pharmaceutical company Aoxing Pharmaceutical Company Inc (nyse mkt:AXN) announced on Monday the receipt by its Chinese subsidiary, from the State Food and Drug Administration of ... See all stories on this topic » | ||
Emerging Growth Pharmaceutical Company creates Gravitational pull towards ... InvestorIdeas.com (press release) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, Vosaroxin, to improve the lives of people with cancer. Sunesis Pharmaceuticals' work ... See all stories on this topic » | ||
Portola and Lee's Pharmaceutical Enter Into Agreement to Expand Phase 3 ... Marketwire (press release) SOUTH SAN FRANCISCO, CA and HONG KONG--(Marketwire - Jan 29, 2013) - Portola Pharmaceuticals, Inc. and Lee's Pharmaceutical (HK) Ltd. ( HKSE : 0950) today announced an agreement to jointly expand the Phase 3 APEX study of betrixaban into ... See all stories on this topic » |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment